ClinicalTrials.Veeva

Menu

the Research of Analgesia and Sedation Effect of Remifentanil on ICU Short Operation

Z

Zhengzhou University

Status and phase

Unknown
Phase 4

Conditions

Critical Illness

Treatments

Drug: Remifentanil
Drug: Remifentanil+Lidocaine
Drug: Lidocaine
Drug: Midazolam

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT02635802
zdyfysicu-1

Details and patient eligibility

About

Remifentanil is one kind of opiates with strong analgesic effect,which has the rapid onset and short lasting duration. Remifentanil usually is used to help reducing the pain of patients with mechanical ventilation in ICU. Maybe it can also be used to ease the pain in ICU small short time operation.The purpose of this study is to determine (1) whether remifentanil is effective in small short time operations in ICU or not, (2) the save range of remifentanil in small short time operations in ICU, (3) and the adverse reaction that happens in these operations.

Enrollment

1,500 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • critically ill patients need endotracheal intubation
  • tracheotomy
  • central venous puncture
  • pleural puncture
  • abdominal puncture
  • lumbar puncture
  • bone marrow puncture
  • fiber bronchoscopic examination
  • other small short-time operations

Exclusion criteria

  • patients allergic to opioids
  • in pregnancy or in feeding
  • with myasthenia gravis
  • with hypovolemia,
  • take monoamine oxidase inhibitor(MAOI) in 14days
  • in coma and GCS<8
  • with bradycardia or hypotension

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

1,500 participants in 3 patient groups

Remifentanil
Experimental group
Description:
injection form concentration 20μg/ml loading dose 1.0-2.0μg/kg intravenous injection slowly,time \>1min,then 5μg/kg·h pumping until the operation is finished.
Treatment:
Drug: Remifentanil
Drug: Midazolam
Lidocaine
Experimental group
Description:
injection form concentration 10mg/ml loading dose 100-400mg local anesthesia
Treatment:
Drug: Lidocaine
Drug: Midazolam
Remifentanil+Lidocaine
Experimental group
Description:
injection form concentration 20μg/ml loading dose 1.0-2.0μg/kg intravenous injection slowly,time \>1min,then 5μg/kg·h pumping until the operation is finished + injection form concentration 10mg/ml loading dose 100-400mg local anesthesia
Treatment:
Drug: Remifentanil+Lidocaine
Drug: Midazolam

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems